Find clinical trials for Multiple Myeloma in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near New Haven, CT, USA:
progression-free survival (PFS) in participants with newly diagnosed multiple myeloma (a blood cancer of plasma cells) who are not ...
Phase 3
New Haven, Connecticut, United States and 211 other locations
(LD-Dex) (Cohort B) in subjects with relapsed or refractory multiple myeloma who have received a first or second line treatment of ...
Phase 2
Stamford, Connecticut, United States and 48 other locations
escalation (Part A and C) and expansion (Parts B and D), first-in-human clinical study of CC-93269 in subjects with relapsed and refractory multiple...
Phase 1
New Haven, Connecticut, United States and 36 other locations
antibody (mAb). Renal impairment is a major complication of multiple myeloma (MM) and the majority of MM participants is either at ...
Phase 1
Stony Brook, New York, United States and 25 other locations
with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple...
Phase 3
New Haven, Connecticut, United States and 256 other locations
The purpose of this study is to assess BMS-986453 in participants with relapsed and/or refractory multiple myeloma (RRMM)....
Phase 1
New Haven, Connecticut, United States and 17 other locations
Multiple myeloma (MM) is an incurable malignancy and accounts for 1 percentage (%) of all cancers and for 10% of all hematologic ma ...
Phase 2
New Haven, Connecticut, United States and 58 other locations
A Study Evaluating Treatment of Multiple Myeloma with Carfilzomib in Combination with Pomalidomide and Dexamethasone...
Phase 2
New Haven, Connecticut, United States and 45 other locations
This is a study to test the safety and effectiveness of the study drug, daratumumab in combination with carfilzomib, lenalidomide and dexamethasone....
Phase 2
Commack, New York, United States and 6 other locations
antibody, daratumumab, can provide more benefit to people with multiple myeloma compared to a combination therapy including daratum ...
Phase 3
Harrison, New York, United States and 273 other locations
Clinical trials
Research sites
Resources
Legal